Follow
Alican Gulsevin
Alican Gulsevin
Butler University COPHS
Verified email at butler.edu - Homepage
Title
Cited by
Cited by
Year
Molecular architecture of the human caveolin-1 complex
JC Porta, B Han, A Gulsevin, JM Chung, Y Peskova, S Connolly, ...
Science advances 8 (19), eabn7232, 2022
592022
Benchmarking AlphaFold2 on peptide structure prediction
EF McDonald, T Jones, L Plate, J Meiler, A Gulsevin
Structure 31 (1), 111-119. e2, 2023
352023
Modeling immunity with rosetta: Methods for antibody and antigen design
CT Schoeder, S Schmitz, J Adolf-Bryfogle, AM Sevy, JA Finn, MF Sauer, ...
Biochemistry 60 (11), 825-846, 2021
312021
Allosteric agonism of α7 nicotinic acetylcholine receptors: Receptor modulation outside the orthosteric site
A Gulsevin, RL Papke, C Stokes, S Garai, GA Thakur, M Quadri, ...
Molecular pharmacology 95 (6), 606-614, 2019
262019
Macroscopic and microscopic activation of α7 nicotinic acetylcholine receptors by the structurally unrelated allosteric agonist-positive allosteric modulators (ago-PAMs) B-973B …
M Quadri, S Garai, GA Thakur, C Stokes, A Gulsevin, NA Horenstein, ...
Molecular pharmacology 95 (1), 43-61, 2019
222019
Sulfonium as a surrogate for ammonium: a new α7 nicotinic acetylcholine receptor partial agonist with desensitizing activity
M Quadri, C Stokes, A Gulsevin, ACJ Felts, KA Abboud, RL Papke, ...
Journal of medicinal chemistry 60 (18), 7928-7934, 2017
152017
In silico modeling of the α7 nicotinic acetylcholine receptor: new pharmacological challenges associated with multiple modes of signaling
A Gulsevin, RL Papke, N Horenstein
Mini reviews in medicinal chemistry 20 (10), 841-864, 2020
102020
An investigation of three-finger toxin—nAChR Interactions through Rosetta protein docking
A Gulsevin, J Meiler
Toxins 12 (9), 598, 2020
92020
Nicotinic receptor pharmacology in silico: Insights and challenges
A Gulsevin
Neuropharmacology 177, 108257, 2020
82020
Template-free prediction of a new monotopic membrane protein fold and assembly by AlphaFold2
A Gulsevin, B Han, JC Porta, HS Mchaourab, J Meiler, AK Kenworthy
Biophysical Journal 122 (11), 2041-2052, 2023
72023
Silent agonists for α7 nicotinic acetylcholine receptors
RL Papke, M Quadri, A Gulsevin
Pharmacological Research 190, 106736, 2023
72023
Prediction of amphipathic helix-membrane interactions with Rosetta
A Gulsevin, J Meiler
Biophysical Journal 120 (3), 19a, 2021
72021
The allosteric activation of α7 nAChR by α-conotoxin MrIC is modified by mutations at the vestibular site
A Gulsevin, RL Papke, C Stokes, HNT Tran, AH Jin, I Vetter, J Meiler
Toxins 13 (8), 555, 2021
62021
Benchmarking Peptide Structure Prediction with AlphaFold2
A Gulsevin, J Meiler
bioRxiv, 2022.02. 17.480937, 2022
42022
Structural analysis of the P132L disease mutation in caveolin-1 reveals its role in the assembly of oligomeric complexes
B Han, A Gulsevin, S Connolly, T Wang, B Meyer, J Porta, A Tiwari, ...
Journal of Biological Chemistry 299 (4), 2023
32023
Template-free prediction of a new monotopic membrane protein fold and oligomeric assembly by Alphafold2
A Gulsevin, B Han, J Porta, H Mchaourab, J Meiler, AK Kenworthy
Biophysical Journal 122 (3), 194a, 2023
32023
Design principles of caveolins across metazoa and beyond
B Han, LFL Wilson, A Gulsevin, J Meiler, E Karakas, AK Kenworthy
bioRxiv, 2022.11. 15.516482, 2022
32022
Veratridine Can Bind to a Site at the Mouth of the Channel Pore at Human Cardiac Sodium Channel NaV1.5
A Gulsevin, AM Glazer, T Shields, BM Kroncke, DM Roden, J Meiler
International Journal of Molecular Sciences 23 (4), 2225, 2022
32022
Structural characterization of a breast cancer-associated mutation in caveolin-1
B Han, A Gulsevin, S Connolly, T Wang, J Porta, A Tiwari, A Deng, ...
bioRxiv, 2022.05. 23.493104, 2022
22022
First crystal structure of a non-canonical amino acid linked to a paramagnetic lanthanide tag facilitates protein structure determination using NMR-derived restraints
E Okwei, S Ganguly, HL Darling, JM Harp, A Gulsevin, I Coin, ...
bioRxiv, 2022.04. 10.487812, 2022
22022
The system can't perform the operation now. Try again later.
Articles 1–20